Press Releases

Calidi is at the forefront of the genetic medicine revolution in cancer and other indications

Read the Latest

Press Release

Calidi Biotherapeutics to Present New Data on Its Lead Asset CLD-401 at the AACR Annual Meeting in April 2026

Read More
News Coverage
Calidi’s Contribution To The Treatment Of COVID-19
In A Short Time, The Novel Coronavirus Disease (COVID-19) Has Destructively Impacted Both The People…
 
Press Release
Stem Cells for COVID-19 | PSC Teams Up with Calidi Biotherapeutics
Recently, Personalized Stem Cells (PSC) was asked by the White House Task Force to apply…
 
Press Release
Calidi Biotherapeutics Announces Appointment of Dr. George Peoples, a Prominent Immuno-Oncology Expert, to its Scientific and Medical Advisory Board
SAN DIEGO– (BUSINESS WIRE)– Calidi Biotherapeutics, Inc. (“Calidi”), a clinical‐stage biotechnology company at the forefront…
 
Press Release
Calidi Biotherapeutics Announces Appointment of Biotech Veteran Heehyoung Lee to Board of Directors
SAN DIEGO– (BUSINESS WIRE)– Calidi Biotherapeutics, Inc. (“Calidi”), a clinical‐stage biotechnology company at the forefront…
 
Press Release
Calidi Biotherapeutics Presents Data at the 2020 ASCO-SITC Clinical Immuno-Oncology Symposium
SAN DIEGO–(BUSINESS WIRE)–Calidi Biotherapeutics, Inc., a clinical‐stage immuno-oncology company at the forefront of cell-based oncolytic…
 
Press Release
Calidi Biotherapeutics Announces Abstract Acceptance For Presentation at the ASCO-SITC Clinical Immuno-Oncology Symposium
Calidi Biotherapeutics, Inc., a clinical‐stage immuno-oncology company at the forefront of cell-based oncolytic virus immunotherapies…